stats Making the Business of Life Easier

   Finance globeinvestor   Careers globecareers.workopolis Subscribe to The Globe
The Globe and Mail /
Home | Business | National | Int'l | Sports | Columnists | The Arts | Tech | Travel | TV | Wheels


  This site         Tips

  The Web Google


  Where to Find It

Breaking News
  Home Page

  Report on Business



Subscribe to The Globe

Shop at our Globe Store

Print Edition
  Front Page

  Report on Business




  Arts & Entertainment



   Headline Index

 Other Sections

  Births & Deaths






  Facts & Arguments




  Real Estate









  Food & Dining




  Online Personals

  TV Listings/News

 Specials & Series
  All Reports...


   Where to Find It
 A quick guide to what's available on the site



  Customer Service

  Help & Contact Us



 Web Site

  E-Mail Newsletters

  Free Headlines

  Globe Store New

  Help & Contact Us

  Make Us Home

  Mobile New

  Press Room

  Privacy Policy

  Terms & Conditions


Pot stocks plunge as CannTrust woes cast shadow over sector

Email this article Print this article
Saturday, July 13, 2019 – Page B1

Cannabis stocks dropped sharply on Friday as the scandal at CannTrust Holdings Inc. continued to shake investor confidence in the sector and raise worries that future deal making could be at risk.

On Thursday, CannTrust announced it is halting all sales while federal regulators investigate the company's manufacturing facility in Vaughan, Ont.

The news came days after CannTrust acknowledged Health Canada had issued it a non-compliance order for growing thousands of kilograms of cannabis in five unlicensed rooms in its 12-room greenhouse in Pelham, Ont. between October, 2018, and March.

CannTrust shares dropped 17.3 per cent on Friday to finish the week down 48.3 per cent, amid concerns that the company could lose its licence or, at least, be forced to destroy thousands of kilograms of product worth tens of millions of dollars.

While the fallout has been particularly dramatic for CannTrust, the implications of Health Canada's investigation are being felt industry-wide.

Institutional investors who were starting to warm to the sector are reassessing their interest. Meanwhile, concerns are mounting that Health Canada may respond to the compliance breach by increasing regulatory demands.

Canopy Growth Corp. declined 7.99 per cent on Friday, while Aurora Cannabis Inc. dropped 5.98 per cent. The Horizons Marijuana Life Sciences Index exchange traded fund, which tracks the Canadian cannabis industry, has declined 8.6 per cent since Monday.

"We advise U.S. banks quite a lot in this space, those who are in deals and those who are thinking about getting into deals, and the top-of-mind issue for them is always legal compliance," said Patricia Olasker, a partner with Davies Ward Phillips & Vineberg LLP who leads the firm's cannabis practice.

"There's always been an amount of skepticism about the Canadian industry's compliance.

We have always pointed out that it is a highly regulated industry, with rigorous rules, and that this should be a great source of comfort. I think people have been comforted by that, and then CannTrust happens and it really shakes people's confidence," she said.

"Any lawyer you talk to will say they have a number of deals that could be impacted by this," she added.

CannTrust, which is led by former chief executive of Tangerine Bank Peter Aceto, was viewed as one of the highest-quality operators in the space. The company is listed on the Toronto Stock Exchange and the New York Stock Exchange, and has partnerships with firms such as drug manufacturer Apotex Inc. and alcohol distributor Breakthru Beverage Group.

In May, CannTrust raised US$170-million in a public offering co-led by Merrill Lynch, Citigroup, Credit Suisse Securities (USA) LLC and RBC Capital Markets.

"It definitely hurts investor confidence. I think that people are seeing everything going on with CannTrust, and probably a question that's on their mind is: Is this going on with other licensed producers?" said Ryan Macdonell, an analyst with GMP Securities, in an interview. Mr. Macdonell changed his rating for CannTrust to "under review" on Friday, indicating an inability to analyze the stock, given the amount of uncertainty surrounding the company.

A significant blow to investor confidence could have major implications for an industry where few companies are cash-flow positive, and most rely on equity financing for both capital expenditures and everyday operations.

Eric Foster, who leads the cannabis practice at Dentons Canada LLP, said that the implications of CannTrust's woes could go beyond the equity markets.

"Increasingly, we're seeing bigger banks come in and more traditional lending opportunities be available to licensed producers.

But something like this is going to be an ongoing diligence concern," he said. "Cannabis companies may find it increasingly challenging to get that commercial bank debt financing, and accordingly will have to look at capital markets. With a depressed stock price it can become problematic." A big unknown in all of this is how Health Canada will respond.

The federal regulator has the power to suspend or revoke CannTrust's licence, although it has not indicated how it intends to proceed.

"Any major failure in a regulated industry is going to lead to more requirements over all for others in that industry. So while [Health Canada] hasn't declared that they would do that, it could certainly be an implication of the fallout," said Karina Lahnakoski, vice-president, quality and regulatory at the consulting firm Cannabis Compliance Inc.

"I came from [the pharmaceutical industry], where whenever there is a major failure, the regulators need to react by putting in more requirements, either more reporting requirements, more inspection requirements, updating their guidance documents. There usually is a reaction. You may not see it right away. But Health Canada will definitely take this as a learning opportunity," Ms. Lahnakoski said.

Health Canada had conducted three inspections on the company's greenhouse since the Cannabis Act came into effect in October, Health Canada spokeswoman Tammy Jarbeau wrote in a statement to The Globe and Mail.

"Prior to the recent inspection at CannTrust's [Pelham] site, which resulted in a non-compliant rating, two inspections were conducted to assess the licence holder's compliance with good production practices (e.g., product quality) and compliance with odour controls," Ms. Jarbeau wrote.

The regulatory situation is particularly worrisome, said Ms.Olasker of Davies, because Health Canada's own monitoring system does not appear to have caught the infraction. Rather, Health Canada appears to have begun its investigation after receiving a whistle-blower tip from a former employee.

"Two things we're telling our clients, is take comfort from the fact that Health Canada reacted very quickly. Within a day or two of being informed of the issue, they were responding," Ms. Olasker said. "I think as well, you might point to this as a stern warning to other producers: Comply or risk a beating in the stock market. That might make the next guy less prepared to pull plywood walls over illegal grow operations."

In an interview with The Globe on Friday, Mr. Aceto, the CEO of CannTrust, said the company decided to halt sales after Health Canada began inspecting the company's facility in Vaughan.

"As an abundance of caution we voluntarily decided that we were just not going to ship product out of our facility until we worked through our discussions with Health Canada," Mr. Aceto said. He declined to say what he or other top management knew about the illegal growing operations.

"We've got this independent committee of the board, they've commissioned a full root-cause analysis, and until that work is done, we're just not in a position to know or articulate exactly what happened," Mr. Aceto said.

Huh? How did I get here?
Return to Main William_Johnson Page
Subscribe to
The Globe and Mail

Email this article Print this article

space  Advertisement

Need CPR for your RSP? Check your portfolio’s pulse and lower yours by improving the overall health of your investments. Click here.


7-Day Site Search

Breaking News

Today's Weather


Rick Salutin
Merrily marching
off to war
Roy MacGregor
Duct tape might hold
when panic strikes

Where Manley is going with his first budget



For a columnist's most recent stories, click on their name below.


Roy MacGregor arrow
This Country
Jeffrey Simpson arrow
The Nation
Margaret Wente arrow
Hugh Winsor  arrow
The Power Game

Rob Carrick arrow
Personal Finance
Drew Fagan arrow
The Big Picture
Mathew Ingram arrow
Brent Jang arrow
Business West
Brian Milner arrow
Taking Stock
Eric Reguly arrow
To The Point
Andrew Willis arrow

Stephen Brunt arrow
The Game
Eric Duhatschek arrow
Allan Maki arrow
William Houston arrow
Truth & Rumours
Lorne Rubenstein arrow
 The Arts

John Doyle arrow
John MacLachlan Gray arrow
Gray's Anatomy
David Macfarlane arrow
Cheap Seats
Johanna Schneller arrow

Murray Campbell arrow
Ontario Politics
Lysiane Gagnon arrow
Inside Quebec
Marcus Gee arrow
The World
William Johnson arrow
Pit Bill
Paul Knox arrow
Heather Mallick arrow
As If
Leah McLaren arrow
Generation Why
Rex Murphy arrow
Japes of Wrath
Rick Salutin arrow
On The Other Hand
Paul Sullivan arrow
The West
William Thorsell arrow

Home | Business | National | Int'l | Sports | Columnists | The Arts | Tech | Travel | TV | Wheels

© 2003 Bell Globemedia Interactive Inc. All Rights Reserved.
Help & Contact Us | Back to the top of this page